APA

Zecchin D., Boscaro V., Medico E., Barault L., Martini M., Arena S., Cancelliere C., Bartolini A., Crowley E. H., Bardelli A., Gallicchio M. & Di Nicolantonio F. (20140804). BRAF V600E is a determinant of sensitivity to proteasome inhibitors. : Molecular cancer therapeutics.

Chicago

Zecchin Davide, Boscaro Valentina, Medico Enzo, Barault Ludovic, Martini Miriam, Arena Sabrina, Cancelliere Carlotta, Bartolini Alice, Crowley Emily H, Bardelli Alberto, Gallicchio Margherita and Di Nicolantonio Federica. 20140804. BRAF V600E is a determinant of sensitivity to proteasome inhibitors. : Molecular cancer therapeutics.

Harvard

Zecchin D., Boscaro V., Medico E., Barault L., Martini M., Arena S., Cancelliere C., Bartolini A., Crowley E. H., Bardelli A., Gallicchio M. and Di Nicolantonio F. (20140804). BRAF V600E is a determinant of sensitivity to proteasome inhibitors. : Molecular cancer therapeutics.

MLA

Zecchin Davide, Boscaro Valentina, Medico Enzo, Barault Ludovic, Martini Miriam, Arena Sabrina, Cancelliere Carlotta, Bartolini Alice, Crowley Emily H, Bardelli Alberto, Gallicchio Margherita and Di Nicolantonio Federica. BRAF V600E is a determinant of sensitivity to proteasome inhibitors. : Molecular cancer therapeutics. 20140804.